Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.56+0.66 (+1.74%)
At close: 04:00PM EDT
38.59 +0.03 (+0.08%)
After hours: 07:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close37.90
Open37.63
Bid38.50 x 1100
Ask38.60 x 3100
Day's Range36.97 - 38.61
52 Week Range36.97 - 55.00
Volume9,291,855
Avg. Volume7,142,811
Market Cap33.326B
Beta (5Y Monthly)0.54
PE Ratio (TTM)6.54
EPS (TTM)5.90
Earnings DateJun 30, 2022
Forward Dividend & Yield1.91 (4.95%)
Ex-Dividend DateMay 19, 2022
1y Target Est45.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for WBA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Walgreens Boots Alliance, Inc.
    Analyst Report: Walgreens Boots Alliance, Inc.Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement